Roos Van Westrhenen
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
CYP2D6 Metabolizer Phenotype Is Associated with Early Antidepressant Discontinuation in the UK Biobank.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 28, 2026
The WPA Section on Genetics in Psychiatry: scientific progress and clinical translation.
Journal: World psychiatry : official journal of the World Psychiatric Association (WPA)
Published: September 15, 2025
Knowledge and Attitudes Regarding Pharmacogenetics of Pharmacists in the Netherlands: A National Online Survey Study.
Journal: Journal of evaluation in clinical practice
Published: September 09, 2025
Recent Advances in Psychopharmacology.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 05, 2025
Personal recovery as outcome measure in mental health research: A meta-analysis on the sensitivity to change properties of the Recovery Assessment Scale.
Journal: Journal of affective disorders
Published: September 04, 2025
Concomitant Psychotropic Medication Is Associated with Reduced Outcomes of Trauma-Focused Psychotherapy for Post-Traumatic Stress Disorder.
Journal: Psychotherapy and psychosomatics
Published: August 13, 2025
Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: April 23, 2025
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and CYP2C19 and tricyclic antidepressants.
Journal: European journal of human genetics : EJHG
Published: March 21, 2025
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between TPMT/NUDT15 and thiopurines.
Journal: European journal of human genetics : EJHG
Published: March 21, 2025
Sex and age effects on prevalence of CYP2C19 and CYP2D6 Phenoconversion risk over time in patients with psychosis.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: January 13, 2025
Unidentified CYP2D6 genotype does not affect pharmacological treatment for patients with first episode psychosis.
Journal: Journal of psychopharmacology (Oxford, England)
Published: September 30, 2024
PSY-PGx: a new intervention for the implementation of pharmacogenetics in psychiatry.
Journal: World psychiatry : official journal of the World Psychiatric Association (WPA)
Published: September 30, 2024
Last Updated: 09/26/2026